project id: TCGA-ACC; case submitter id: TCGA-OR-A5L6; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 8.8; age at index: 60; days to birth: -22057; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22057; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 861.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 80.0; sample id: 0f19f2d5-d552-4f7a-88d8-bb559cb1cd0f; sample submitter id: TCGA-OR-A5L6-01A; portion id: 343f207e-3617-46c8-820f-d4ddea5d7372; portion submitter id: TCGA-OR-A5L6-01A-11; slide id: 363a865d-a83a-4bd8-bc5f-bcaf5deae95b; slide submitter id: TCGA-OR-A5L6-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; section location: TOP;